The Role of the New Zealand Intensive Medicines Monitoring Programme in Identification of Previously Unrecognised Signals of Adverse Drug Reactions

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|1|2|169-178

ISSN： 1574-8863

Source： Current Drug Safety, Vol.1, Iss.2, 2006-05, pp. : 169-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An overview on adverse drug reactions to traditional Chinese medicines

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 834-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

An overview on adverse drug reactions to traditional Chinese medicines

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 834-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics and adverse drug reactions

By Amur Shashi   Zineh Issam   Abernethy Darrell R   Huang Shiew-Mei   Lesko Lawrence J  

Personalized Medicine, Vol. 7, Iss. 6, 2010-11 ,pp. : 633-642

Future Medicine

Access to resources Recommend Favorite

Prevalence of Adverse Drug Reactions

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 6, 1990-06 ,pp. : 722-722

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adverse drug reactions in dermatology

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 2, 2015-03 ,pp. : 105-110

John Wiley & Sons Inc

Access to resources Recommend Favorite